INGENERON, INC.

Profile

Company Names

INGENERON, INC.

Addresses

8205 EL RIO, HOUSTON, TX 77054

Phone Numbers

8328664525

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$21,766,761.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2024-02-16 
$1,749,181.00 
$1,749,181.00 
$0.00 
Equity 
4
2019-04-05 
$3,500,000.00 
$23,000,000.00 
$19,500,000.00 
Equity 
3
2017-02-17 
$9,867,575.00 
$19,867,575.00 
$10,000,000.00 
Equity 
2
2016-08-04 
$2,150,000.00 
$2,150,000.00 
$0.00 
Debt 
1
2015-10-09 
$4,500,005.00 
$4,500,005.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ECKHARD 
 
ALT 
EXECUTIVE OFFICER, DIRECTOR
INGENERON, INC.
FABIAN 
 
ALT 
EXECUTIVE OFFICER, DIRECTOR
INGENERON, INC.
ECKHARD 
 
ALT, M.D., PH.D 
DIRECTOR
INGENERON, INC.
ECKHARD 
U. 
ALT, M.D., PH.D. 
DIRECTOR
INGENERON, INC.
MICHAEL 
 
COLEMAN 
EXECUTIVE OFFICER
INGENERON, INC.   |  INHABITIQ PARENT, LLC   |  TAIKA CAPITAL LONG SHORT EQUITY OFFSHORE FUND, LTD.   |  CONNECTED2FIBER, INC.   |  SINGULARITY TOPCO LLC   |  CONNECTBASE HOLDINGS, INC.
BOBBY 
 
GRIFFIN 
DIRECTOR
GDC GROUP HOLDINGS, LLC   |  GDC HOLDINGS, INC.   |  VALENTX INC   |  CSW INDUSTRIALS, INC.   |  INGENERON, INC.
JERRY 
 
GRIFFIN 
DIRECTOR
EVERA MEDICAL, INC   |  GUIDED DELIVERY SYSTEMS INC   |  INSPIRE MEDICAL SYSTEMS, INC.   |  INGENERON, INC.
JERRY 
 
GRIFFIN, M.D. 
DIRECTOR
INGENERON, INC.
BOBBY 
 
GRIFFIN, MS 
DIRECTOR
INGENERON, INC.
KLAUS 
 
KELLER 
DIRECTOR
INGENERON, INC.
KELBY 
 
KRABBENHOFT 
DIRECTOR
INGENERON, INC.
AMBER 
 
LANGNER 
DIRECTOR
INGENERON, INC.
ANGELO 
 
MOESSLANG 
EXECUTIVE OFFICER
INGENERON, INC.
RON 
 
STUBBERS 
EXECUTIVE OFFICER
INGENERON, INC.
ANNETTE 
 
WHITE 
DIRECTOR
INGENERON, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-03-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-16 
2019-04-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-05 
2017-03-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-17 
2016-12-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-08-04 
2016-07-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#